
Vital Farms (VITL) Increases Despite Market Slip: Here's What You Need to Know
Vital Farms (VITL) concluded the recent trading session at $28.45, signifying a +1.14% move from its prior day's close.
Loading news...

Vital Farms (VITL) concluded the recent trading session at $28.45, signifying a +1.14% move from its prior day's close.

Vital Farms (VITL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The latest trading day saw Vital Farms (VITL) settling at $28.38, representing a -5.75% change from its previous close.

Emerald Advisers LLC trimmed its holdings in Vital Farms, Inc. (NASDAQ: VITL) by 2.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 990,625 shares of the company's stock after selling 24,600 shares during the quarter. Vital Farms accounts for 1.3% of Emerald

In the closing of the recent trading day, Vital Farms (VITL) stood at $29.55, denoting a -3.4% move from the preceding trading day.

Founder and Executive Chairperson Matthew O'Hayer sold 25,000 shares on Jan. 2, 2026, generating a transaction value of ~$771,300 based on the weighted average sale price. This sale represented approximately 0.37% of Mr.

Vital Farms (VITL) concluded the recent trading session at $29.82, signifying a -6.64% move from its prior day's close.

United Natural Foods, Beyond Meat, Vital Farms and General Mills are betting big on organic, clean-label foods and redefining what's healthy on store shelves.

AUSTIN, Texas--(BUSINESS WIRE)--Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today announced that Russell Diez-Canseco, President and Chief Executive Officer, Thilo Wrede, Chief Financial Officer, and Brian Shipman, Vice President of Investor Relations, will participate in the 28th Annual ICR Conference in Orlando, FL on Monday, January 12 and Tuesday, January 13, 2026. Vital Farms will be available for 1x1 meetings and will h.

E. Ohman J or Asset Management AB acquired a new position in Vital Farms, Inc. (NASDAQ: VITL) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 46,240 shares of the company's stock, valued at approximately $1,903,000. E. Ohman J or

Freshpet (NASDAQ: FRPT - Get Free Report) and Vital Farms (NASDAQ: VITL - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Valuation and Earnings This table compares Freshpet and

Vital Farms, Inc. (NASDAQ: VITL - Get Free Report) CEO Russell Diez-Canseco sold 16,734 shares of the business's stock in a transaction on Monday, December 15th. The shares were sold at an average price of $35.05, for a total transaction of $586,526.70. Following the transaction, the chief executive officer directly owned 649,684 shares in the company,

Vital Farms, Inc. maintains robust growth, leveraging ethical branding and supply chain advantages to deliver strong sales and margin expansion. VITL's 2025 guidance remains solid despite temporary ERP disruptions, with ambitious 2030 targets of $2 billion in sales and 15–17% EBITDA margins. VITL shares currently trade at about 20x earnings (ex-cash), with resilient fundamentals and a strong net cash position supporting further upside.

Vital Farms, Inc. (VITL) Analyst/Investor Day Transcript

Vital Farms announced that it hopes to grow its sales from $712 million over the last year to $2 billion by 2030. However, management adjusted 2026 revenue guidance downward as the company implements a new ordering system.

AUSTIN, Texas--(BUSINESS WIRE)--Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, updated its long-term financial targets and plans to provide additional detail at its Investor Day presentation later today. “We see a clear multi-year path toward $2 billion in Net Revenue by 2030 and 15% to 17% adjusted EBITDA margins by 2030, with Gross Margins of 35+% between 2025 and 2030. As we continue to drive increased brand awareness, expand.

Medifast (NYSE: MED - Get Free Report) and Vital Farms (NASDAQ: VITL - Get Free Report) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

NEW YORK , Dec. 8, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600: Ares Management (NYSE: ARES) will replace Kellanova (NYSE: K) in the S&P 500 effective prior to the open of trading on Thursday, December 11. Mars Inc. is acquiring Kellanova in a deal expected to close soon, pending final closing conditions.

Vital Farms, Inc. (VITL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript